Pharmaceutical Social Enterprise
OWP Pharmaceuticals enjoys a heartfelt, strategic and innovative relationship with the ROW Foundation. Together they form a concerted organization with shared goals and values that result in true Pharmaceutical Social Enterprise. OWP uses commercial success for the common good by supporting humanitarian projects rather than maximizing profits.
OWP Pharmaceuticals delivers quality branded generic epilepsy medications that are replicable and fairly priced. Our strategic focus is to support neurologists and patients in the U.S. with beneficial products and to use the majority of the profits to provide resources for those living with epilepsy in under-resourced areas of the world by donating to the ROW Foundation.
Big Pharma is dominated by companies who sink billions into research, spend billions on marketing and snap up billions in sales. Not a lot of this money is channeled into social enterprises targeted on the developing world. This is because the industry is highly regulated, very complex and driven by the bottom line. OWP branded generics offer highly consistent dosage and potency controls at very affordable prices. We can reduce the expense of medication by as much as 90 percent from the patented versions and still generate profits to assist people in need.Scott Boyer, Founder and President of OWP
We assist people living with epilepsy in need by partnering with the ROW Foundation to improve the diagnosis and treatment available to these under-resourced patients and their families. This symbiotic relationship enables us to better serve the entire epilepsy community. One World. One Standard!
“Imagine a loved one suffering with epilepsy in the U.S. Now multiply their challenges ten times over and you begin to get a sense of what those with epilepsy in under-resourced areas of the world go through physically, emotionally and socially. We aim to help mitigate their suffering by leveling the field when it comes to treating epilepsy. My sister-in-law, a niece and a nephew all wrestled with the disorder. I’ve seen the life-changing difference the right medications and treatment can make and I desperately want everyone with epilepsy to have the same chance for a better future.”Dr. Paul Regan, President of ROW
ROW also partners with neurologists from the developed world in training their counterparts in under-resourced areas to improve their ability to diagnose and treat epilepsy. Learn more about what we’re doing now.